Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 8, 2022
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
Maury Raycroft Upgraded (TYRA) to Strong Buy and Decreased Target to $27 on, Mar 8th, 2022
Maury Raycroft of Jefferies, Upgraded "Tyra Biosciences, Inc." (TYRA) to Strong Buy and Decreased Target from $31 to $27 on, Mar 8th, 2022.
Maury, nor any peers, have made any analyst calls on TYRA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30